Verdunity Competitors

Esri is the global market leader in geographic information system (GIS) software, location intelligence, and mapping. Since 1969, we have supported customers with geographic science and geospatial analytics, what we call The Science of Where. We take a geographic approach to problem-solving, brought to life by modern GIS technology.

UrbanFootprint delivers Resilient Decision Intelligence – trusted by some of the largest energy utilities, financial institutions, government agencies, and private organizations as they deploy billions of dollars to effect change in the face of climate risk, the urgent need to decarbonize and growing social instability. UrbanFootprint’s mission is to Build Resilience. We empower institutions with critical data insights to drive decision making and inform where to invest and build the next generation of resilient infrastructure and communities. UrbanFootprint was born out of over 25 years of urban planning, data science, and disaster response experience and offers the only comprehensive, national view of climate, environmental, urban, and socio-economic data available - rigorously cleaning and aligning thousands of previously-siloed industry relevant data layers from numerous sources across 160 million U.S. Parcels. We combine and intersect particular metrics and models to construct Resilience Insights delivered with intuitive mapping tools purpose built to answer complex resource questions — where to invest, where to deploy resources, and where to optimize for risk, return, resilience, and community.

The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 300 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.